Abbott Showcases Innovations in AACC Roundtable
The Abbott Innovation Roundtable at AACC highlighted the company’s latest strides forwards in the molecular diagnostics, point-of-care, and bio-identification sectors.
Read MoreSearch Results for: point-of-care testing
Inside Track: Study Time
Although enacted primarily as the annual “doc fix” to prevent severe cuts in the Medicare rates for physicians, the Protecting Access to Medicare Act of 2014 also embodies the first serious effort in 30 years to legislate a reform of the Centers for Medicare and Medicaid Services Clinical Laboratory Fee Schedule.
Read More
James McNally to Head Ativa Medical
Developer of the world’s first micro lab hires new leadership in preparation for clinical studies and commercialization.
Read More
Inside Track: Making the Move to HbA1c Testing
Abbott Launches New HbA1c Test Cleared for Diabetes Diagnosis
Read More
QuantuMDx Closes Investment Round for Prototyping Handheld Molecular Diagnostics Device
Following the success of its Indiegogo crowdfunding campaign, handheld molecular diagnostics device pioneer QuantuMDx Group recently announced it had closed an $8.42 million funding round with philanthropist private investors and the University of Newcastle upon Tyne.
Read More